Source: Journal of Allergy and Clinical Immunology. Unidade: FM
Subjects: ALERGIA E IMUNOLOGIA, BRONCOPATIAS, ASMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RAVENSBERG, A. Janneke et al. Eotaxin-2 and eotaxin-3 expression is associated with persistent eosinophilic bronchial inflammation in patients with asthma after allergen challenge. Journal of Allergy and Clinical Immunology, v. 115, n. 4, p. 779-785, 2004Tradução . . Disponível em: https://doi.org/10.1016/j.jaci.2004.11.045. Acesso em: 12 maio 2024.APA
Ravensberg, A. J., Ricciardolo, F. L. M., Schadewijk, A. van, Rabe, K. F., Sterk, P. J., Hiemstra, P. S., & Mauad, T. (2004). Eotaxin-2 and eotaxin-3 expression is associated with persistent eosinophilic bronchial inflammation in patients with asthma after allergen challenge. Journal of Allergy and Clinical Immunology, 115( 4), 779-785. doi:10.1016/j.jaci.2004.11.045NLM
Ravensberg AJ, Ricciardolo FLM, Schadewijk A van, Rabe KF, Sterk PJ, Hiemstra PS, Mauad T. Eotaxin-2 and eotaxin-3 expression is associated with persistent eosinophilic bronchial inflammation in patients with asthma after allergen challenge [Internet]. Journal of Allergy and Clinical Immunology. 2004 ; 115( 4): 779-785.[citado 2024 maio 12 ] Available from: https://doi.org/10.1016/j.jaci.2004.11.045Vancouver
Ravensberg AJ, Ricciardolo FLM, Schadewijk A van, Rabe KF, Sterk PJ, Hiemstra PS, Mauad T. Eotaxin-2 and eotaxin-3 expression is associated with persistent eosinophilic bronchial inflammation in patients with asthma after allergen challenge [Internet]. Journal of Allergy and Clinical Immunology. 2004 ; 115( 4): 779-785.[citado 2024 maio 12 ] Available from: https://doi.org/10.1016/j.jaci.2004.11.045
